Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction (REAGIR)
Sponsor: Aravind Eye Care System
Listed as NCT05110001, this PHASE3 trial focuses on Acanthamoeba Keratitis and Fungal Keratitis and remains completed. Sponsored by Aravind Eye Care System, it has been updated 15 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
-
Aug 2025 — Feb 2026 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 10 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2024 — Jun 2024 [monthly]
Recruiting PHASE3
-
Jun 2023 — Jan 2024 [monthly]
Recruiting PHASE3
-
May 2023 — Jun 2023 [monthly]
Recruiting PHASE3
-
Feb 2023 — May 2023 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE3
-
Apr 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2022 — Apr 2022 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2021 — Jan 2022 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aravind Eye Care System
- Federal University of São Paulo
- National Eye Institute (NEI)
- Stanford University
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .